Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Medpace Holdings's share price for the quarter that ended in Sep. 2024 was $333.8. Medpace Holdings's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 31 Mil. Therefore, Medpace Holdings's market cap for the quarter that ended in Sep. 2024 was $10,375 Mil.
Medpace Holdings's quarterly market cap
increased
from Mar. 2024 ($12,522 Mil) to Jun. 2024 ($12,768 Mil) but then
declined
from Jun. 2024 ($12,768 Mil) to Sep. 2024 ($10,375 Mil).
Medpace Holdings's annual market cap
declined
from Dec. 2021 ($7,837 Mil) to Dec. 2022 ($6,604 Mil) but then
increased
from Dec. 2022 ($6,604 Mil) to Dec. 2023 ($9,427 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Medpace Holdings's Enterprise Value for Today is $10,060 Mil.
Medpace Holdings Market Cap Historical Data
The historical data trend for Medpace Holdings's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Medpace Holdings's Market Cap
For the Diagnostics & Research subindustry, Medpace Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medpace Holdings's Market Cap Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Medpace Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Medpace Holdings's Market Cap falls into.
Medpace Holdings Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Medpace Holdings's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medpace Holdings (NAS:MEDP) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Medpace Holdings Market Cap Related Terms
Thank you for viewing the detailed overview of Medpace Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MEDP has been successfully added to your 